Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Eurofins Scientific SE's Enterprise Value is $17,448 Mil.
Eurofins Scientific SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $943 Mil. Therefore, Eurofins Scientific SE's EV-to-EBIT ratio for today is 18.51.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Eurofins Scientific SE (OTCPK:ERFSF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Eurofins Scientific SE's current Enterprise Value is $17,448 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $943 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Eurofins Scientific SE's EV-to-EBITDA for today is:
Eurofins Scientific SE's current Enterprise Value is $17,448 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $1,783 Mil.
Eurofins Scientific SE's current Enterprise Value is $17,448 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $8,480 Mil.
Eurofins Scientific SE's current Enterprise Value is $17,448 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $1,629 Mil.
Eurofins Scientific SE's current Enterprise Value is $17,448 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $656 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE Enterprise Value Related Terms
Eurofins Scientific SE Enterprise Value Historical Data
* Premium members only.
The historical data trend for Eurofins Scientific SE's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ERFSF vs TMO, DHR, IDXX: Enterprise Value Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Enterprise Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Enterprise Value falls into.
Eurofins Scientific SE Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Eurofins Scientific SE's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE (ERFSF) has a Enterprise Value of $17,448 Mil as of Jun. 24, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Eurofins Scientific SE and its competitors.
Is Eurofins Scientific SE's Enterprise Value too high?
Eurofins Scientific SE's current Enterprise Value is $17,448 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Enterprise Value compare to TMO and DHR?
Eurofins Scientific SE's Enterprise Value of $17,448 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Enterprise Value is $17,448 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $76.00, compared to a current price of $76.03 — trading 0% above its estimated fair value. The current Enterprise Value is $17,448 Mil. Eurofins Scientific SE's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Enterprise Value is $17,448 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $76.03 is trading 0% above its estimated GF Value™ of $76.00.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
Enterprise Value: $17,448 Mil
GF Value™: $76.00 vs. price of $76.03 (0% above fair value)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
81GF Score
Get the complete analysis for ERFSF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 
